NewEdge Wealth LLC Buys 1,820 Shares of Cigna Group $CI

NewEdge Wealth LLC raised its position in Cigna Group (NYSE:CI) by 30.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,815 shares of the health services provider’s stock after buying an additional 1,820 shares during the quarter. NewEdge Wealth LLC’s holdings in Cigna Group were worth $2,151,000 at the end of the most recent reporting period.

Other hedge funds have also recently made changes to their positions in the company. Beacon Financial Strategies CORP bought a new stake in shares of Cigna Group in the fourth quarter valued at $28,000. Collier Financial bought a new stake in shares of Cigna Group in the third quarter valued at $34,000. Lodestone Wealth Management LLC bought a new stake in shares of Cigna Group in the fourth quarter valued at approximately $32,000. Activest Wealth Management raised its position in shares of Cigna Group by 1,050.0% in the fourth quarter. Activest Wealth Management now owns 138 shares of the health services provider’s stock valued at $38,000 after purchasing an additional 126 shares during the period. Finally, Founders Capital Management raised its position in shares of Cigna Group by 53.0% in the third quarter. Founders Capital Management now owns 153 shares of the health services provider’s stock valued at $44,000 after purchasing an additional 53 shares during the period. 86.99% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on CI shares. Wells Fargo & Company boosted their price target on shares of Cigna Group from $300.00 to $305.00 and gave the company an “equal weight” rating in a research report on Friday, May 1st. Truist Financial boosted their price target on shares of Cigna Group from $320.00 to $350.00 and gave the company a “buy” rating in a research report on Tuesday, February 17th. Raymond James Financial set a $340.00 price objective on Cigna Group in a research note on Friday, May 1st. Cantor Fitzgerald boosted their price objective on Cigna Group from $325.00 to $340.00 and gave the company an “overweight” rating in a research note on Friday, May 1st. Finally, TD Cowen boosted their price objective on Cigna Group from $333.00 to $338.00 and gave the company a “buy” rating in a research note on Monday, February 9th. One analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Cigna Group has a consensus rating of “Moderate Buy” and an average target price of $338.35.

Insider Transactions at Cigna Group

In other news, insider Nicole S. Jones sold 2,307 shares of the stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $666,515.37. Following the transaction, the insider owned 32,647 shares of the company’s stock, valued at $9,432,044.77. This represents a 6.60% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Everett Neville sold 1,719 shares of the stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $496,636.29. Following the completion of the transaction, the insider directly owned 5,670 shares in the company, valued at $1,638,119.70. The trade was a 23.26% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.60% of the stock is owned by corporate insiders.

Cigna Group Stock Performance

Cigna Group stock opened at $298.44 on Wednesday. The firm’s 50 day simple moving average is $274.53 and its 200 day simple moving average is $275.99. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.69. The firm has a market capitalization of $78.95 billion, a PE ratio of 12.65, a price-to-earnings-growth ratio of 1.01 and a beta of 0.30. Cigna Group has a 1-year low of $239.51 and a 1-year high of $338.89.

Cigna Group (NYSE:CI) last posted its earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, topping analysts’ consensus estimates of $7.60 by $0.19. The business had revenue of $68.52 billion for the quarter, compared to analyst estimates of $66.29 billion. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. Cigna Group’s revenue was up 4.6% on a year-over-year basis. During the same quarter in the prior year, the firm posted $6.74 EPS. Cigna Group has set its FY 2026 guidance at 30.350- EPS. As a group, analysts expect that Cigna Group will post 30.39 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th will be paid a $1.56 dividend. This represents a $6.24 dividend on an annualized basis and a yield of 2.1%. The ex-dividend date is Thursday, June 4th. Cigna Group’s dividend payout ratio is currently 26.45%.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.